- Home
- TFC vs TAK Comparison
TFC vs TAK Comparison
Compare TFC & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFC
- TAK
- Stock Information
- Founded
- TFC 1872
- TAK 1781
- Country
- TFC United States
- TAK Japan
- Employees
- TFC N/A
- TAK N/A
- Industry
- TFC Major Banks
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- TFC Finance
- TAK Health Care
- Exchange
- TFC Nasdaq
- TAK Nasdaq
- Market Cap
- TFC 52.4B
- TAK 45.8B
- IPO Year
- TFC N/A
- TAK N/A
- Fundamental
- Price
- TFC $45.15
- TAK $15.13
- Analyst Decision
- TFC Buy
- TAK
- Analyst Count
- TFC 18
- TAK 0
- Target Price
- TFC $49.06
- TAK N/A
- AVG Volume (30 Days)
- TFC 7.2M
- TAK 2.2M
- Earning Date
- TFC 07-18-2025
- TAK 07-30-2025
- Dividend Yield
- TFC 4.61%
- TAK 3.59%
- EPS Growth
- TFC N/A
- TAK N/A
- EPS
- TFC 3.42
- TAK 0.45
- Revenue
- TFC $11,531,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- TFC $81.29
- TAK $1.01
- Revenue Next Year
- TFC $4.70
- TAK $1.04
- P/E Ratio
- TFC $13.22
- TAK $66.24
- Revenue Growth
- TFC N/A
- TAK 7.45
- 52 Week Low
- TFC $33.56
- TAK $12.80
- 52 Week High
- TFC $49.06
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- TFC 72.67
- TAK 50.18
- Support Level
- TFC $44.92
- TAK $14.93
- Resistance Level
- TFC $45.84
- TAK $15.53
- Average True Range (ATR)
- TFC 0.79
- TAK 0.15
- MACD
- TFC 0.39
- TAK -0.02
- Stochastic Oscillator
- TFC 90.00
- TAK 50.00
About TFC Truist Financial Corporation
Based in Charlotte, North Carolina, Truist is the combination of BB&T and SunTrust. Truist is a regional bank with a presence primarily in the Southeastern United States. In addition to commercial banking, retail banking, and investment banking operations, the company operates several nonbank segments.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.